JTO lung cancer research (IMAGE)

Virginia Commonwealth University

JTO lung cancer research

Caption

FGTI-2734 and sotorasib are synergistic at inhibiting the viability of sotorasib-resistant (Calu-1 and LU99) and sotorasib-sensitive (H2122 and H358) human KRAS G12C lung cancer cells.

Credit

Kazi, Aslamuzzaman et al. Journal of Thoracic Oncology, Volume 20, Issue 3, 331 - 344

Usage Restrictions

This figure can only be used in conjunction with reporting on this study.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.